Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Smoking Cessation Pharmacotherapy Efficacy in Comorbid Medical Populations: Secondary Analysis of the Evaluating Adverse Events in a Global Smoking Cessation Study (EAGLES) Randomized Clinical Trial

Nicotine & Tobacco Research(2023)10.1093/ntr/ntad126Source: DataRank Database

Smoking Cessation Pharmacotherapy Efficacy in Comorbid Medical Populations: Secondary Analysis of the Evaluating Adverse Events in a Global Smoking Cessation Study (EAGLES) Randomized Clinical Trial is a research paper published in Nicotine & Tobacco Research (2023). On theSindex it has a DataRank of 0. It has been cited 9 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access9 citations

Download PDF

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 1.27)OA: greenTopics (41)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (4)

Amanda Palmer ORCID,Nathaniel L. Baker ORCID,Benjamin A. Toll ORCID,Alana M. Rojewski ORCID

Live enrichment

PubMed:37474127 PMC:PMC10734386 OpenAlex:https://openalex.org/W4384925919

National Cancer Institute

Grant: K07CA214839

National Heart, Lung, and Blood Institute

Grant: NIH-T32-HL144470

NHLBI NIH HHS

Grant: T32 HL144470

NIAMS NIH HHS

Grant: K24 AR060297

FWCI

1.27

Citation Percentile

0.8%

Citation Trend

2024

2025

2026

greenLicense: https://academic.oup.com/pages/standard-publication-reuse-rights

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC10734386/pdf/ntad126.pdf

publisherhttps://academic.oup.com/ntr/advance-article-pdf/doi/10.1093/ntr/ntad126/51175210/ntad126.pdf

publisherhttps://academic.oup.com/ntr/article-pdf/26/1/31/54709180/ntad126.pdf

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/10734386

Fields of Study

Smoking Behavior and CessationDiabetes Management and EducationChronic Obstructive Pulmonary Disease (COPD) ResearchHumansSmoking CessationVareniclineBupropionNicotinic AgonistsTobacco Use Cessation DevicesComorbidityDiabetes MellitusTreatment OutcomeBenzazepinesQuinoxalines

MeSH Terms

VareniclineBenzazepinesDiabetes MellitusHumansQuinoxalinesComorbiditySmoking CessationBupropionTreatment OutcomeNicotinic AgonistsTobacco Use Cessation Devices

Keywords

MedicineComorbiditySmoking cessationVareniclineInternal medicineRandomized controlled trialBupropionAbstinencePlaceboOdds ratioCohortAdverse effectNicotine replacement therapyPhysical therapyNicotinePsychiatry

Sustainable Development Goals

SDG 0: Good health and well-being